BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29419436)

  • 21. Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia.
    Stam RW; den Boer ML; Passier MM; Janka-Schaub GE; Sallan SE; Armstrong SA; Pieters R
    Leukemia; 2006 Feb; 20(2):264-71. PubMed ID: 16357833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unusual profiles of pediatric acute lymphoblastic leukemia with MLL gene rearrangement.
    Kubicka M; Soszynska K; Mucha B; Rafinska B; Kolodziej B; Haus O; Styczynski J
    Leuk Lymphoma; 2007 Oct; 48(10):2083-6. PubMed ID: 17917979
    [No Abstract]   [Full Text] [Related]  

  • 23. The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias.
    Andersson AK; Ma J; Wang J; Chen X; Gedman AL; Dang J; Nakitandwe J; Holmfeldt L; Parker M; Easton J; Huether R; Kriwacki R; Rusch M; Wu G; Li Y; Mulder H; Raimondi S; Pounds S; Kang G; Shi L; Becksfort J; Gupta P; Payne-Turner D; Vadodaria B; Boggs K; Yergeau D; Manne J; Song G; Edmonson M; Nagahawatte P; Wei L; Cheng C; Pei D; Sutton R; Venn NC; Chetcuti A; Rush A; Catchpoole D; Heldrup J; Fioretos T; Lu C; Ding L; Pui CH; Shurtleff S; Mullighan CG; Mardis ER; Wilson RK; Gruber TA; Zhang J; Downing JR;
    Nat Genet; 2015 Apr; 47(4):330-7. PubMed ID: 25730765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relatively favorable prognosis for MLL-rearranged childhood acute leukemia with reciprocal translocations.
    Yang L; Ding L; Liang J; Chen J; Tang Y; Xue H; Gu L; Shen S; Li B; Chen J
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27266. PubMed ID: 29943896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MLL gene rearrangements have no direct impact on Ara-C sensitivity in infant acute lymphoblastic leukemia and childhood M4/M5 acute myeloid leukemia.
    Stam RW; Hubeek I; den Boer ML; Buijs-Gladdines JG; Creutzig U; Kaspers GJ; Pieters R
    Leukemia; 2006 Jan; 20(1):179-82. PubMed ID: 16307022
    [No Abstract]   [Full Text] [Related]  

  • 26. Rearrangements of ATP5L-KMT2A in acute lymphoblastic leukaemia.
    Ferrari A; Ghelli Luserna Di Rora A; Domizio C; Papayannidis C; Simonetti G; Maria Hernández-Rivas J; Rondoni M; Giglio F; Abruzzese E; Imovilli A; Iacobucci I; Calistri D; Martinelli G
    Br J Haematol; 2021 Mar; 192(6):e139-e144. PubMed ID: 33314053
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia.
    Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y
    J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement.
    Bardini M; Woll PS; Corral L; Luc S; Wittmann L; Ma Z; Lo Nigro L; Basso G; Biondi A; Cazzaniga G; Jacobsen SE
    Leukemia; 2015 Jan; 29(1):38-50. PubMed ID: 24798483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemosensitivity is differentially regulated by the SDF-1/CXCR4 and SDF-1/CXCR7 axes in acute lymphoblastic leukemia with MLL gene rearrangements.
    Ando N; Furuichi Y; Kasai S; Tamai M; Harama D; Kagami K; Abe M; Goi K; Inukai T; Sugita K
    Leuk Res; 2018 Dec; 75():36-44. PubMed ID: 30453100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGFβ1 synergizes with FLT3 ligand to induce chemoresistant quiescence in acute lymphoblastic leukemia with MLL gene rearrangements.
    Tamai M; Furuichi Y; Kasai S; Ando N; Harama D; Goi K; Inukai T; Kagami K; Abe M; Ichikawa H; Sugita K
    Leuk Res; 2017 Oct; 61():68-76. PubMed ID: 28917156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MLL gene in maternal and infantile acute lymphoblastic leukemia and the effect of estrogen.
    Aljurf M; Saleh AJ; Ahmed SO
    Leuk Res; 2011 Jul; 35(7):e127. PubMed ID: 21396712
    [No Abstract]   [Full Text] [Related]  

  • 32. Spontaneous reversion of a lineage switch following an initial blinatumomab-induced ALL-to-AML switch in
    Wölfl M; Rasche M; Eyrich M; Schmid R; Reinhardt D; Schlegel PG
    Blood Adv; 2018 Jun; 2(12):1382-1385. PubMed ID: 29898879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic chemical and molecular profiling of MLL-rearranged infant acute lymphoblastic leukemia reveals efficacy of romidepsin.
    Cruickshank MN; Ford J; Cheung LC; Heng J; Singh S; Wells J; Failes TW; Arndt GM; Smithers N; Prinjha RK; Anderson D; Carter KW; Gout AM; Lassmann T; O'Reilly J; Cole CH; Kotecha RS; Kees UR
    Leukemia; 2017 Jan; 31(1):40-50. PubMed ID: 27443263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MLL-rearranged infant leukaemia: A 'thorn in the side' of a remarkable success story.
    Rice S; Roy A
    Biochim Biophys Acta Gene Regul Mech; 2020 Aug; 1863(8):194564. PubMed ID: 32376390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale.
    Stumpel DJ; Schotte D; Lange-Turenhout EA; Schneider P; Seslija L; de Menezes RX; Marquez VE; Pieters R; den Boer ML; Stam RW
    Leukemia; 2011 Mar; 25(3):429-39. PubMed ID: 21116279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MLL-rearranged mixed phenotype acute leukemia masquerading as B-cell ALL.
    Yang W; Tran P; Khan Z; Rezk S; O'Brien S
    Leuk Lymphoma; 2017 Jun; 58(6):1498-1501. PubMed ID: 27774846
    [No Abstract]   [Full Text] [Related]  

  • 37. Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia.
    Stam RW; Schneider P; de Lorenzo P; Valsecchi MG; den Boer ML; Pieters R
    Blood; 2007 Oct; 110(7):2774-5. PubMed ID: 17881645
    [No Abstract]   [Full Text] [Related]  

  • 38. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
    Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G
    Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxicity, drug combinability, and biological correlates of ABT-737 against acute lymphoblastic leukemia cells with MLL rearrangement.
    Jayanthan A; Incoronato A; Singh A; Blackmore C; Bernoux D; Lewis V; Stam R; Whitlock JA; Narendran A
    Pediatr Blood Cancer; 2011 Mar; 56(3):353-60. PubMed ID: 21225911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and molecular epidemiology of neonatal leukemia in Brazil.
    Moura SV; Andrade F; Magalhães IQ; Costa I; Silva DB; D'Andrea ML; Pinheiro VP; Lee ML; Werneck F; Emerenciano M; Pombo-de-Oliveira MS
    Leuk Lymphoma; 2015 Apr; 56(4):903-9. PubMed ID: 24991719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.